원텍
Financials
Valuation Metrics
원텍's Market Cap is ₩3415B. At end of 2025 it was ₩6919B. Ranked #570 of 2,410 in KR market (top 24%), #229 of 1,631 on KOSDAQ (top 14%), #16 of 94 in Health Care Equipment & Services (top 17%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 341.50B KRW | KR#570/2,410 Sec#16/94 |
| Revenue | 167.35B KRW | KR#1,121/2,410 Sec#17/94 |
| Net Income | 39.99B KRW | KR#489/2,410 Sec#11/94 |
| Total Assets | 278.76B KRW | KR#1,077/2,410 Sec#25/94 |
| Net Assets | 173.02B KRW | KR#1,040/2,410 Sec#27/94 |
| Employees | 228 | KR#1,001/2,410 Sec#30/94 |
| Value | ||
| P/E | 8.54x | KR#757/2,410 Sec#22/94 |
| P/B | 1.97x | KR#1,977/2,410 Sec#70/94 |
| PEG | 28.90x | KR#834/2,410 Sec#33/94 |
| P/S | 2.04x | KR#1,862/2,410 Sec#55/94 |
| EV/EBITDA | 8.06x | KR#520/2,410 Sec#14/94 |
| FCF Yield | 14.62% | KR#486/2,410 Sec#10/94 |
| Profitability | ||
| ROE | 23.11% | KR#126/2,410 Sec#5/94 |
| ROA | 14.34% | KR#129/2,410 Sec#9/94 |
| Op. Margin | 25.19% | KR#95/2,410 Sec#6/94 |
| Revenue Growth | 18.77% | KR#582/2,410 Sec#31/94 |
| Earnings Growth | 0.30% | KR#829/2,410 Sec#33/94 |
| Financial Health | ||
| Debt Ratio | 61.12% | KR#1,106/2,410 Sec#63/94 |
| Total Debt | 31.24B KRW | KR#1,205/2,410 Sec#30/94 |
| FCF | 49.94B KRW | KR#298/2,410 Sec#4/94 |
| Cash | 33.08B KRW | KR#944/2,410 Sec#24/94 |
| Current Ratio | 6.44x | KR#190/2,410 Sec#18/94 |
| Net Debt/EBITDA | -0.04x | KR#598/2,410 Sec#23/94 |
| Dividend | ||
| Div. Yield | 1.31% | KR#1,070/2,410 Sec#33/94 |
| Div. Growth | 0.00% | KR—/2,410 Sec—/94 |
| Performance | ||
| 1Y Return | -55.00% | KR#2,083/2,410 Sec#77/94 |
| 1M Return | -23.65% | KR#2,059/2,410 Sec#88/94 |
| From 52W High | -63.50% | KR#1,820/2,410 Sec#65/94 |
| 1Y MDD | -63.55% | KR#1,640/2,410 Sec#58/94 |
| Trading | ||
| Volume | 300,721 shares | KR#314/2,410 Sec#14/94 |
| Trading Value | 1.14B KRW | KR#623/2,410 Sec#17/94 |
| Foreign Own. | 3.36% | KR#1,181/2,410 Sec#40/94 |
| Per Share | ||
| EPS | 448 KRW | KR#1,035/2,410 Sec#29/94 |
| BPS | 1,938 KRW | KR#2,091/2,410 Sec#70/94 |
Company Info
Established in 1999 as a specialized medical device company, Wontech is headquartered in Yuseong-gu, Daejeon Metropolitan City, having completed a merger with Daishin Balance No. 8 Special Purpose Acquisition Company in 2022. It primarily manufactures and sells skin aesthetics lasers and energy-based medical devices, including Oligio, Picocare, and Lavieen, actively exporting to Asia, Europe, the Middle East, and South America. The company diversifies its product lineup through RF and HIFU technology development and strengthens competitiveness by developing Monopolar RF Oligio.